Dr. Helen Dimaras discusses how empowering Retinoblastoma survivors and their families to have a greater role in the decision-making process of research projects has led to more inclusive, high-quality, and translatable results. The Canadian Retinoblastoma Research Advisory Board (CRRAB) is co-directed by patients, clinicians, allied healthcare providers, researchers, patient engagement experts, and policymakers.